Citations

Showing 10 of 108081 citations.

Extracellular vesicles from bone marrow–derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury
Haga, Hiroaki , Borrelli, David A., Matsuda, Akiko , Parasramka, Mansi, Shukla, Neha , Lee, David D. , Yan, Irene K. , Patel, Tushar , Lee, David D

Mayo Clinic

Liver Transplantation | April 13, 2017 | Volume: 23 | Issue: 6 | Pages: 791-803

10.1002/lt.24770 | PMID 28407355 Get It

Hepatic ischemia/reperfusion injury (IRI) and associated inflammation contributes to liver dysfunction and complications after liver surgery and transplantation. Mesenchymal stem cells (MSCs) have been reported to reduce hepatic IRI because of their reparative immunomodulatory effects in injured tissues. Recent studies have highlighted beneficial effects of extracellular vesicles from mesenchymal stem cells (MSC‐EV) on tissue injury. The effects of systemically administered mouse bone marrow–derived MSC‐EV were evaluated in an experimental murine model of hepatic IRI induced by cross‐clamping the hepatic artery and portal vein for 90 minutes followed by reperfusion for periods of up to 6 hours. Compared with controls, intravenous administration of MSC‐EV 30 minutes prior to IRI dramatically reduced the extent of tissue necrosis, decreased caspase 3–positive and apoptotic cells, and reduced serum aminotransferase levels. MSC‐EV increased hepatic messenger RNA (mRNA) expression of NACHT, LRR, and PYD domains‐containing protein 12, and the chemokine (C‐X‐C motif) ligand 1, and reduced mRNA expression of several inflammatory cytokines such as interleukin 6 during IRI. MSC‐EV increased cell viability and suppressed both oxidative injury and nuclear factor kappa B activity in murine hepatocytes in vitro. In conclusion, the administration of extracellular vesicles derived from bone marrow–derived MSCs may ameliorate hepatic IRI by reducing hepatic injury through modulation of the inflammatory response.Liver Transplantation 23 791–803 2017 AASLD.
Thomas E. Starzl, M.D., Ph.D. (1926–2017)
Rakela, Jorge , Fung, John J.

Mayo Clinic

Hepatology | April 13, 2017 | Volume: 66 | Issue: 1 | Pages: 306-308

10.1002/hep.29214 | PMID 28407325 Get It

A cardiovascular prescreening protocol for unmonitored in‐office laryngology procedures
Madden, Lyndsay L. , Ward, Anne , Young, VyVy N. , Smith, Libby J. , Bryson, Paul C. , Clary, Matthew S. , Weissbrod, Phillip A., Bock, Jonathan M. , Blumin, Joel H. , Rosen, Clark A. , Weissbrod, Philip A. , Ward, John , Lott, David G. , Weissbrod, Phil, Clary, Matthew S , Weissbrod, Philip A

Mayo Clinic

The Laryngoscope | April 13, 2017 | Volume: 127 | Issue: 8 | Pages: 1845-1849

10.1002/lary.26481 | PMID 28407258 Get It

ObjectivesCurrently, there are no cardiovascular (CV) preprocedure screening parameters for patients undergoing in‐office laryngeal procedures (IOLP). Studies have shown significant changes in CV measures for IOLP. The aim was to develop and evaluate a pre‐IOLP CV screening protocol.MethodsReview of IOLP literature and consultation with an anesthesiologist and cardiologist led to the development of CV parameters and questions related to four metabolic equivalents (METS) of work as a patient‐screening tool before IOLP. A separate cohort was screened with only a modified CV protocol. All patients were screened for heart rate (HR) and blood pressure (BP) elevation prior to the procedure. Need for further CV evaluation was characterized as systolic blood pressure BP >160, diastolic BP >100, and/or HR >110 beats/minute. Patients whose BP/HR exceeded these values were referred to their primary care physician (PCP) before re‐screening. If parameters were exceeded again at the second screen, then the procedure was done under monitored anesthesia care.ResultsThe first study phase included 56 patients. The fail rate was 40% largely related to four METS of work. The second study phase included 440 patients. The screen fail rate was 15 patients of 572 (2.6%). Of these, 12 patients of 132 (9.1%) failed the initial screen and were sent to their PCP for further evaluation, and five of 440 (1.4%) patients failed on the day of the procedure. Overall, five of 440 (1.5%) patients would qualify to have their site of service changed for their laryngology procedure from an unmonitored to a monitored setting due to the prescreening criteria.ConclusionFew patients needed further workup based upon the in‐office CV parameters set in this study. Patients with CV risk factors were identified by the screening protocol. Having established hemodynamic parameters in place may improve the safety of IOLP with a very low physician burden.Level of Evidence2b Laryngoscope, 127:1845–1849, 2017
Introduction to the Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee Guideline for Prevention of Surgical Site Infection: Prosthetic Joint Arthroplasty Section
Segreti, John , Berbari, Elie F. , Ricks, Philip, Berríos-Torres, Sandra I., Berbari, Elie, Parvizi, Javad

Mayo Clinic

Surgical Infections | April 13, 2017 | Volume: 18 | Issue: 4 | Pages: 394-400

10.1089/sur.2017.068 | PMID 28407472 Get It

Brief Report: Robo1 Regulates the Migration of Human Subventricular Zone Neural Progenitor Cells During Development
Guerrero‐Cazares, Hugo , Lavell, Emily , Chen, Linda , Schiapparelli, Paula , Lara‐Velazquez, Montserrat , Capilla‐González, Vivian , Clements, Anna Christina , Drummond, Gabrielle, Noiman, Liron, Thaler, Katrina, Burke, Anne E. , Quiñones‐Hinojosa, Alfredo , Capilla-González, Vivian , Guerrero-Cazares, Hugo

Mayo Clinic

Stem Cells | April 13, 2017 | Volume: 35 | Issue: 7 | Pages: 1860-1865

10.1002/stem.2628 | PMID 28406573 Get It

Abstract Human neural progenitor cell (NPC) migration within the subventricular zone (SVZ) of the lateral ganglionic eminence is an active process throughout early brain development. The migration of human NPCs from the SVZ to the olfactory bulb during fetal stages resembles what occurs in adult rodents. As the human brain develops during infancy, this migratory stream is drastically reduced in cell number and becomes barely evident in adults. The mechanisms regulating human NPC migration are unknown. The Slit–Robo signaling pathway has been defined as a chemorepulsive cue involved in axon guidance and neuroblast migration in rodents. Slit and Robo proteins expressed in the rodent brain help guide neuroblast migration from the SVZ through the rostral migratory stream to the olfactory bulb. Here, we present the first study on the role that Slit and Robo proteins play in human-derived fetal neural progenitor cell migration (hfNPC). We describe that Robo1 and Robo2 isoforms are expressed in the human fetal SVZ. Furthermore, we demonstrate that Slit2 is able to induce a chemorepellent effect on the migration of hfNPCs derived from the human fetal SVZ. In addition, when Robo1 expression is inhibited, hfNPCs are unable to migrate to the olfactory bulb of mice when injected in the anterior SVZ. Our findings indicate that the migration of human NPCs from the SVZ is partially regulated by the Slit–Robo axis. This pathway could be regulated to direct the migration of NPCs in human endogenous neural cell therapy.
An Early Assessment of the ACGME CLER Program: A National Survey of Designated Institutional Officials
Long, Timothy R. , Doherty, Julie, Frimannsdottir, Katrin R., Rose, Steven H.

Mayo Clinic

Journal of Graduate Medical Education | April 13, 2017 | Volume: 9 | Issue: 3 | Pages: 330-335

10.4300/jgme-d-16-00489.1 | PMID 28638512 Get It

ABSTRACT Background The Accreditation Council for Graduate Medical Education (ACGME) Clinical Learning Environment Review (CLER) is an innovative element of the ACGME's new accreditation system. To date, little information has been collected regarding the value of CLER. Objective The purpose of this study is to collect information on designated institutional officials' (DIOs') perspectives about the initial CLER visits conducted at their institutions. Methods The authors created and distributed a survey to DIOs about their initial CLER visits. Demographic data were compared across survey responses with Spearman's rank correlation and the Kruskal-Wallis test. Results The authors received responses from 63% of DIOs (186 of 297) at institutions that participated in the initial CLER visits, with 88% (164 of 186) having served as DIO during the visit. Seventy-two percent (114 of 158) reported institutional changes to address CLER focus areas prior to the visit, yet only 32% (51 of 157) reported that additional resources were allocated to these areas after the site visit. Sixty-five percent (102 of 156) reported institutional executive leadership was positive about participating in CLER; 85% (134 of 158) reported that ACGME conducted the visits efficiently; 84% (133 of 158) reported that the site visit accurately assessed the institution's performance in the CLER focus areas; and 60% (93 of 156) reported CLER provided high-value information. Conclusion Survey results from DIOs suggest that CLER is an effective mechanism to improve the learning environment. Common concerns included limited advance notice for the site visit and disruptions of clinical practice.
Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology
Ezzati, Ali , Wang, Cuiling , Altschul, Dorothea , Katz, Mindy J. , Lipton, Richard B. , Dickson, Dennis W. , Derby, Carol A.

Mayo Clinic

Journal of the American Geriatrics Society | April 13, 2017 | Volume: 65 | Issue: 8 | Pages: 1836-1841

10.1111/jgs.14903 | PMID 28407205 Get It

Objectives To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease ( AD ) pathology. Design Prospective cohort study. Setting Community sample. Participants Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements The Blessed Information‐Memory‐Concentration ( BIMC ) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion ( MVL ) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed‐effects models. Results Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVL s had faster cognitive decline than those with no MVL s (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVL s and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.
Functionalized Carbon Nanotube and Graphene Oxide Embedded Electrically Conductive Hydrogel Synergistically Stimulates Nerve Cell Differentiation
Liu, Xifeng , Park, Sungjo , Waletzki, Brian E., Zhou, Zifei , Lu, Lichun , Miller, A. Lee , Miller, Alan Lee , Terzic, André

Mayo Clinic

ACS Applied Materials & Interfaces | April 13, 2017 | Volume: 9 | Issue: 17 | Pages: 14677-14690

10.1021/acsami.7b02072 | PMID 28406608 Get It

The yin and yang of autophagy in AL amyloidosis
Dispenzieri, Angela

Mayo Clinic

Blood | April 13, 2017 | Volume: 129 | Issue: 15 | Pages: 2044-2045

10.1182/blood-2017-02-765594 | PMID 28408419 Get It

Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma
Rolfes, Mary , Juhn, Young J. , Sheen, Youn Ho, Juhn, Young Jun, Wi, Chung‐Il

Mayo Clinic

Tuberculosis and Respiratory Diseases | April 13, 2017 | Volume: 80 | Issue: 2 | Pages: 113

10.4046/trd.2017.80.2.113 | PMID 28416952 Get It